OTC:ELTP | Free Cash Flow | ELITE PHARMACEUTICALS INC /NV/

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2011-03-31 to 2026-06-30
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-06-30$10.07M$808,964.00$9.26M156.68%
2026-03-31$9.15M$398,016.00$8.75M47.39%
2025-06-30$14.78M$218,204.00$14.56M
2025-03-31$3.92M$754,110.00$3.16M18.61%
2024-06-30$3.14M$778,527.00$2.37M384.22%
2024-03-31$2.1M$403,646.00$1.7M50.99%
2023-06-30-$2.71M
2023-03-31$2.97M$536,211.00$2.43M
2022-06-30-$557,516.00$94,597.00-$652,113.00-213.19%
2022-03-31$1.61M
2021-06-30$1.72M
2021-03-31-$749,368.00
2020-06-30$807,423.00
2020-03-31-$1.21M
2019-06-30$188,273.00
2019-03-31-$2.14M
2018-06-30-$1.71M
2018-03-31-$1.01M
2017-06-30-$1.09M
2017-03-31-$4.08M
2016-06-30-$764,172.00
2016-03-31$606,426.00
2015-06-30$1.89M
2015-03-31-$3.86M
2014-06-30-$4.21M
2014-03-31-$1.48M
2013-06-30-$355,047.00
2013-03-31-$476,685.00
2012-06-30-$297,383.00
2012-03-31$395,016.00
2011-06-30$239,089.00
2011-03-31$1.23M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31$23.75M$925,626.00$22.82M50.86%
2025-03-31$7.46M$1.63M$5.83M
2024-03-31-$3.24M$809,653.00-$4.04M-20.11%
2023-03-31$3.34M$5.74M-$2.4M-67.32%
2022-03-31$6.51M$498,566.00$6.01M67.54%
2021-03-31$3.19M
2020-03-31-$1.79M
2019-03-31-$6.79M
2018-03-31-$4.81M
2017-03-31-$7.88M
2016-03-31-$2.77M
2015-03-31-$15.1M
2014-03-31-$4.22M
2013-03-31-$1.94M
2012-03-31-$394,082.00
2011-03-31$1.55M